Role of spermidine in the expression of late markers of adipose conversion. Effects of growth hormone.
Confluent Ob1771 cells treated with an inhibitor of spermidine and spermine synthesis, methylglyoxyal bis(guanylhydrazone), were dependent on putrescine addition for the expression of glycerol-3-phosphate dehydrogenase and acyl-CoA synthetase, which behaved as late markers of adipose conversion. A similar dependence was observed with drug-treated Ob17MT18 and 3T3-F442A preadipocyte cells, but not with non-differentiating 3T3-C2 cells. Studies in drug-treated Ob1771 cells at the mRNA level showed that the parallel expression of mRNAs encoding for glycerol-3-phosphate dehydrogenase and an homologue of serine proteinases of Mr 28,000 [Cook, Groves, Min & Spiegelman (1985) Proc. Natl. Acad. Sci. U.S.A. 82, 6480-6484] was also dependent on putrescine addition. Double-isotope experiments with [14C]putrescine and [3H]spermidine, as well as analysis of the polyamine content in drug-treated Ob1771 cells under various conditions, demonstrate after putrescine addition that the expression of late markers of adipose conversion was highly correlated with a 2-fold increase in the intracellular concentration of spermidine. No correlation was observed with changes in the intracellular concentrations of putrescine and spermine. Long-term exposure of untreated Ob1771 cells to growth hormone, which led to the expression of late markers of adipose conversion [Doglio, Dani, Grimaldi & Ailhaud (1986) Biochem. J. 238, 123-129] was also accompanied by the same increase in spermidine concentration, which attained values identical with those determined in drug-treated cells supplemented with putrescine. This observation suggests that the permissive effect of growth hormone on the terminal differentiation of adipose cells might e related to changes in the intracellular concentration of spermidine.
D000273:Adipose Tissue / Q000187:drug effects / Q000378:metabolism*; D002454:Cell Differentiation; D002460:Cell Line; D003066:Coenzyme A Ligases / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D005786:Gene Expression Regulation; D005993:Glycerolphosphate Dehydrogenase / Q000378:metabolism; D013006:Growth Hormone / Q000494:pharmacology*; D008071:Lipoprotein Lipase / Q000378:metabolism; D011073:Polyamines / Q000378:metabolism / Q000494:pharmacology; D011700:Putrescine / Q000494:pharmacology; D012097:Repressor Proteins; D029701:Saccharomyces cerevisiae Proteins; D013095:Spermidine / Q000502:physiology*; D000098859:Long-Chain-Fatty-Acid-CoA Ligase
D011073:Polyamines; D012097:Repressor Proteins; D029701:Saccharomyces cerevisiae Proteins; D013006:Growth Hormone; D005993:Glycerolphosphate Dehydrogenase; D008071:Lipoprotein Lipase; D003066:Coenzyme A Ligases; C090799:FAA2 protein, S cerevisiae; D000098859:Long-Chain-Fatty-Acid-CoA Ligase; D013095:Spermidine; D011700:Putrescine